| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |